J&J's first-quarter profit beats estimates even as Stelara sales disappoint
Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a steep falloff in sales of its blockbuster autoimmune drug Stelara.
By · April 14, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a steep falloff in sales of its blockbuster autoimmune drug Stelara.
Leave a Reply